Attorney John J. Fumero of Nason, Yeager, Gerson, White & Lioce, P.A. recently completed five years as Program Chair of the Water Law Institute’s Annual Florida Water Law & Policy Conference in Tampa, FL. The Keynote speech was “Emerging Florida Water Law and Policy Legislative Needs and … [Read more...]
Nason Yeager Relocates Main Offices to The Seacoast Banking Centre in Palm Beach Gardens
In order to better serve our clients, Nason, Yeager, Gerson, White & Lioce, P.A. (Nason Yeager) has relocated our main offices from West Palm Beach to The Seacoast Banking Centre in Palm Beach Gardens. The Seacoast Banking Centre is located at 3001 PGA Boulevard, Suite 305, directly in … [Read more...]
John Fumero and R. Gregory Hyden Prevail in Crosstown Parkway Bridge Project Lawsuit
Attorneys John J. Fumero and R. Gregory Hyden, of Nason, Yeager, Gerson, White & Lioce, P.A. successfully represented the city of Port St. Lucie in a lawsuit by local environmentalists trying to block construction of the Crosstown Parkway bridge. On November 5, 2015, a federal judge granted the … [Read more...]
Attorney John Fumero Represents Vindicated Martin County and County Commissioners
Attorney John J. Fumero, of Nason, Yeager, Gerson, White & Lioce, P.A. represented Martin County and Martin County Commissioners in a lawsuit alleging a violation of Florida’s Public Records Act. On September 3, 2015, Martin County Circuit Court Judge F. Shields McManus, entered an Order on … [Read more...]
Florida Water Law & Policy Conference
We are at a key juncture in Florida! Now in its 10th year, this all-new program brings together professionals from around the state to address the hottest issues surrounding environmental and water law in Florida. Download Brochure Register Now! … [Read more...]
Nason Yeager Represents Cocrystal Pharma, Inc. In Merger With RFS Pharma, LLC
Shareholder Michael D. Harris, Esq. led a team of attorneys from Nason Yeager in representing Bothell, WA based Cocrystal Pharma, Inc. [OTCBB: COCP] in its merger with Tucker, GA based RFS Pharma, LLC. Structured as a merger of equals, the transaction had a fully diluted market value of … [Read more...]